BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23623711)

  • 1. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton having a 7-amide side chain and their pharmacologies.
    Watanabe Y; Kitazawa S; Nemoto T; Hirayama S; Iwai T; Fujii H; Nagase H
    Bioorg Med Chem; 2013 Jun; 21(11):3032-50. PubMed ID: 23623711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a new opioid ligand having the oxabicyclo[3.2.1]octane skeleton using a new rearrangement reaction.
    Watanabe A; Fujii H; Nakajima M; Hasebe K; Mochizuki H; Nagase H
    Bioorg Med Chem Lett; 2009 May; 19(9):2416-9. PubMed ID: 19349178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology. Part 2: Propellane derivatives with an amide side chain.
    Nagase H; Akiyama J; Nakajima R; Hirayama S; Nemoto T; Gouda H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2775-9. PubMed ID: 22460026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and structure-activity relationship of novel opioid κ receptor selective agonists: α-iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Iwai T; Gouda H; Hirono S; Nagasea H
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4980-3. PubMed ID: 25283554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
    Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
    Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain.
    Nakajima R; Yamamoto N; Hirayama S; Iwai T; Saitoh A; Nagumo Y; Fujii H; Nagase H
    Bioorg Med Chem; 2015 Oct; 23(19):6271-9. PubMed ID: 26346669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of non-specific recognition of delta, mu, and kappa opioid receptors.
    Filizola M; Villar HO; Loew GH
    Bioorg Med Chem; 2001 Jan; 9(1):69-76. PubMed ID: 11197347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.
    Deekonda S; Rankin D; Davis P; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem; 2016 Jan; 24(2):85-91. PubMed ID: 26712115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential structure of opioid κ receptor agonist nalfurafine for binding to the κ receptor 3: synthesis of decahydro(iminoethano)phenanthrene derivatives with an oxygen functionality at the 3-position and their pharmacologies.
    Fujii H; Imaide S; Hirayama S; Nemoto T; Gouda H; Hirono S; Nagase H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7711-4. PubMed ID: 23103094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
    Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of opioid receptor-binding affinity of elaeocarpenine and its analogs.
    Kurasaki H; Okamoto I; Morita N; Tamura O
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1601-3. PubMed ID: 20144865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
    Greiner E; Spetea M; Krassnig R; Schüllner F; Aceto M; Harris LS; Traynor JR; Woods JH; Coop A; Schmidhammer H
    J Med Chem; 2003 Apr; 46(9):1758-63. PubMed ID: 12699394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
    Neumeyer JL; Zhang A; Xiong W; Gu XH; Hilbert JE; Knapp BI; Negus SS; Mello NK; Bidlack JM
    J Med Chem; 2003 Nov; 46(24):5162-70. PubMed ID: 14613319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 14-alkoxymorphinans. 22.(1) Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities.
    Lattanzi R; Spetea M; Schüllner F; Rief SB; Krassnig R; Negri L; Schmidhammer H
    J Med Chem; 2005 May; 48(9):3372-8. PubMed ID: 15857143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.
    Bourgeois C; Werfel E; Galla F; Lehmkuhl K; Torres-Gómez H; Schepmann D; Kögel B; Christoph T; Straßburger W; Englberger W; Soeberdt M; Hüwel S; Galla HJ; Wünsch B
    J Med Chem; 2014 Aug; 57(15):6845-60. PubMed ID: 25062506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.